Ethanol induces vascular relaxation via redox-sensitive and nitric oxide-dependent pathways
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
24/09/2013
24/09/2013
01/01/2012
|
Resumo |
We investigated the role of reactive oxygen species (ROS) and nitric oxide (NO) in ethanol-induced relaxation. Vascular reactivity experiments showed that ethanol (0.03-200 mmol/L) induced relaxation in endothelium-intact and denuded rat aortic rings isolated from male Wistar rats. Pre-incubation of intact or denuded rings with L-NAME (non selective NOS inhibitor, 100 mu mol/L), 7-nitroindazole (selective nNOS inhibitor, 100 mu mol/L), ODQ (selective inhibitor of guanylyl cyclase enzyme, I mu mol/L), glibenclamide (selective blocker of ATP-sensitive K+ channels, 3 mu mol/L) and 4-aminopyridine (selective blocker of voltage-dependent K+ channels, 4-AP, 1 mmol/L) reduced ethanol-induced relaxation. Similarly, tiron (superoxide anion (O-2(-)) scavenger, 1 mmol/L) and catalase (hydrogen peroxide (H2O2) scavenger, 300 U/mL) reduced ethanol-induced relaxation to a similar extent in both endothelium-intact and denuded rings. Finally, prodifen (non-selective cytochrome P450 enzymes inhibitor, 10 mu mol/L) and 4-methylpyrazole (selective alcohol dehydrogenase inhibitor, 10 mu mol/L) reduced ethanol-induced relaxation. In cultured aortic vascular smooth muscle cells (VSMCs), ethanol stimulated generation of NO, which was significantly inhibited by L-NAME. In endothelial cells, flow cytometry studies showed that ethanol increased cytosolic Ca2+ concentration ([Ca2+]c), O-2(-) and cytosolic NO concentration ([NO]c). Tiron inhibited ethanol-induced increase in [Ca-2]c and [NO]c. The major new finding of this work is that ethanol induces relaxation via redox-sensitive and NO-cGMP-dependent pathways through direct effects on ROS production and NO signaling. These findings identify putative molecular mechanisms whereby ethanol, at pharmacological concentrations, influences vascular reactivity. (C) 2011 Elsevier Inc. All rights reserved. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/60076-7] Canadian Institute of Health Research (CIHR) [44018] Canadian Institute of Health Research (CIHR) HSFC HSFC Canada Research Chair/Canadian Foundation for Innovation Canada Research Chair/Canadian Foundation for Innovation |
Identificador |
VASCULAR PHARMACOLOGY, NEW YORK, v. 56, n. 41306, pp. 74-83, JAN-FEB, 2012 1537-1891 http://www.producao.usp.br/handle/BDPI/33646 10.1016/j.vph.2011.11.006 |
Idioma(s) |
eng |
Publicador |
ELSEVIER SCIENCE INC NEW YORK |
Relação |
VASCULAR PHARMACOLOGY |
Direitos |
openAccess Copyright ELSEVIER SCIENCE INC |
Palavras-Chave | #ETHANOL #AORTA #RELAXATION #NITRIC OXIDE #REACTIVE OXYGEN SPECIES #AORTIC ENDOTHELIAL-CELLS #CORONARY-HEART-DISEASE #HYDROGEN-PEROXIDE #BLOOD-PRESSURE #ALCOHOL-CONSUMPTION #SMOOTH-MUSCLE #PHOSPHOLIPASE A(2) #SUPEROXIDE #ACTIVATION #SYNTHASE #PHARMACOLOGY & PHARMACY |
Tipo |
article original article publishedVersion |